EIT Digital launches work on early screening system for detection of cognitive disorders // EIT Digital

EIT Digital launches work on early screening system for detection of cognitive disorders

EIT Digital launches work on early screening system for detection of cognitive disorders

EIT Digital has launched ELEMENT, a new Innovation Activity to facilitate faster, earlier diagnosis and intervention for cognitive decline.

Dementia is a cognitive disorder, caused by neurodegenerative diseases, such as Alzheimer's disease or strokes, which lead to a loss of autonomy and are associated with significant decrease in quality of life. In 2015 around the world, there were 9.9 million new cases of dementia: one every 3 seconds*. This number is expected to double every 20 years and reach 68% of the worldwide population in 2050 (mostly in low-medium income countries and due, in part, to fewer births and a growing elderly population.

Jan Alexandersson, activity leader of ELEMENT from DFKI GmbH, Saarbrücken, Germany comments: "Today, dementia is diagnosed through a series of tests and investigations which are time consuming, expensive and even stressful. Diagnosis is often done late as the disease has progressed and first signs are already obvious."

"We will use 2017 to adapt the technology that is currently in use for American English speakers to British English and French. Between October and December, we hope to be able to evaluate the solution and be ready for commercialisation in 2018. Our primary targets would be homecare and professional practitioners."

"We are planning to launch our startup during the first quarter of 2017 and although we aim to reach across Europe with our solution, we will probably target the French and UK markets first," Alexandersson adds.

ELEMENT is part of EIT Digital's Digital Wellbeing Action Line. The main aim of the activity is to bring a unique new product to the European market that:

  • Enables light-touch screening for cognitive decline in clinical and non-clinical settings;
  • Provides risk assessment;
  • Results in faster, cheaper and earlier diagnosis and intervention.

Partners involved in the innovation activity are:

  • DFKI GmbH: Activity lead, coordination, mobile and app integration
  • INRIA: Corpus collection and clinical trials
  • University of Edinburgh : Trials and validation of current system for British English

The innovation activity will also include two third parties:

  • ELEMENT Startup (sub grantee of DFKI & Business Champion): In charge of technology transfer from Winterlight Labs (Toronto)
  • Innovation Alzheimer (sub grantee of INRIA): Clinical partner providing access to dementia patients for French corpus collection and tests. Clinical personnel will be involved.

*Source: Alzheimer's Disease International

The Digital Wellbeing Action Line leverages digital technologies to stay healthy (prevention and early detection) or cope with an existing chronic condition. Both physical and mental wellbeing are considered. The solutions generally rely on enabling consumers to be well-informed about their wellbeing and to be able to use digital instrumentation to monitor and improve their quality of life, according to the motto "an ounce of prevention is worth at least a pound of cure."

*EIT Digital seeks to generate significant innovations from top European research. As such, we focus our investments on a limited number of innovation areas known as Innovation Action Lines, that we have selected with respect to their European relevance and leadership potential. Each Innovation Action Line comprises a portfolio of activities including:
  • open innovation activities carried out by the EIT Digital Partners, and
  • fast-growing technology startups that are ready to scale commercially.
Our Innovation Activities deliver new products or services, create startups and spinoffs to commercialize outputs from projects, and encourage the transfer of technologies for market entry.

© 2010-2018 EIT Digital IVZW. All rights reserved. Legal notice. Privacy Policy.